The Global Psoriasis Market is on a clear and robust upward trajectory. The strong projected CAGR of 9.20% through 2032 underscores a continued shift toward targeted, high-efficacy drug classes, notably biologics. As pharmaceutical giants continue to innovate and biosimilar competition int